154 related articles for article (PubMed ID: 19465351)
1. [Immunohistochemical demonstration of mutant nucleophosmin in acute myeloid leukemia: biological and clinical features related to NPMc expression].
Bedekovics J; Rejto L; Telek B; Udvardy M; Ujfalusi A; Oláh E; Hevessy Z; Kappelmayer J; Kajtár B; Méhes G
Orv Hetil; 2009 May; 150(22):1031-5. PubMed ID: 19465351
[TBL] [Abstract][Full Text] [Related]
2. Cytoplasmic mutated nucleophosmin is stable in primary leukemic cells and in a xenotransplant model of NPMc+ acute myeloid leukemia in SCID mice.
Falini B; Martelli MP; Mecucci C; Liso A; Bolli N; Bigerna B; Pucciarini A; Pileri S; Meloni G; Martelli MF; Haferlach T; Schnittger S
Haematologica; 2008 May; 93(5):775-9. PubMed ID: 18367491
[TBL] [Abstract][Full Text] [Related]
3. Cell line OCI/AML3 bears exon-12 NPM gene mutation-A and cytoplasmic expression of nucleophosmin.
Quentmeier H; Martelli MP; Dirks WG; Bolli N; Liso A; Macleod RA; Nicoletti I; Mannucci R; Pucciarini A; Bigerna B; Martelli MF; Mecucci C; Drexler HG; Falini B
Leukemia; 2005 Oct; 19(10):1760-7. PubMed ID: 16079892
[TBL] [Abstract][Full Text] [Related]
4. Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications.
Falini B; Bolli N; Liso A; Martelli MP; Mannucci R; Pileri S; Nicoletti I
Leukemia; 2009 Oct; 23(10):1731-43. PubMed ID: 19516275
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia.
Falini B; Martelli MP; Bolli N; Bonasso R; Ghia E; Pallotta MT; Diverio D; Nicoletti I; Pacini R; Tabarrini A; Galletti BV; Mannucci R; Roti G; Rosati R; Specchia G; Liso A; Tiacci E; Alcalay M; Luzi L; Volorio S; Bernard L; Guarini A; Amadori S; Mandelli F; Pane F; Lo-Coco F; Saglio G; Pelicci PG; Martelli MF; Mecucci C
Blood; 2006 Sep; 108(6):1999-2005. PubMed ID: 16720834
[TBL] [Abstract][Full Text] [Related]
6. Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biologic and clinical features.
Falini B; Nicoletti I; Martelli MF; Mecucci C
Blood; 2007 Feb; 109(3):874-85. PubMed ID: 17008539
[TBL] [Abstract][Full Text] [Related]
7. Mutated nucleophosmin detects clonal multilineage involvement in acute myeloid leukemia: Impact on WHO classification.
Pasqualucci L; Liso A; Martelli MP; Bolli N; Pacini R; Tabarrini A; Carini M; Bigerna B; Pucciarini A; Mannucci R; Nicoletti I; Tiacci E; Meloni G; Specchia G; Cantore N; Di Raimondo F; Pileri S; Mecucci C; Mandelli F; Martelli MF; Falini B
Blood; 2006 Dec; 108(13):4146-55. PubMed ID: 16926285
[TBL] [Abstract][Full Text] [Related]
8. Cytoplasmic expression of nucleophosmin accurately predicts mutation in the nucleophosmin gene in patients with acute myeloid leukemia and normal karyotype.
Luo J; Qi C; Xu W; Kamel-Reid S; Brandwein J; Chang H
Am J Clin Pathol; 2010 Jan; 133(1):34-40. PubMed ID: 20023256
[TBL] [Abstract][Full Text] [Related]
9. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.
Falini B; Mecucci C; Tiacci E; Alcalay M; Rosati R; Pasqualucci L; La Starza R; Diverio D; Colombo E; Santucci A; Bigerna B; Pacini R; Pucciarini A; Liso A; Vignetti M; Fazi P; Meani N; Pettirossi V; Saglio G; Mandelli F; Lo-Coco F; Pelicci PG; Martelli MF;
N Engl J Med; 2005 Jan; 352(3):254-66. PubMed ID: 15659725
[TBL] [Abstract][Full Text] [Related]
10. Cytoplasmic localization of nucleophosmin in bone marrow blasts of acute myeloid leukemia patients is not completely concordant with NPM1 mutation and is not predictive of prognosis.
Konoplev S; Huang X; Drabkin HA; Koeppen H; Jones D; Kantarjian HM; Garcia-Manero G; Chen W; Medeiros LJ; Bueso-Ramos CE
Cancer; 2009 Oct; 115(20):4737-44. PubMed ID: 19637342
[TBL] [Abstract][Full Text] [Related]
11. Identification of NPMc+ acute myeloid leukemia in bone marrow smears.
Bedekovics J; Rejtő L; Telek B; Kiss A; Hevessy Z; Ujfalusi A; Méhes G
Appl Immunohistochem Mol Morphol; 2013 Jan; 21(1):73-8. PubMed ID: 22595947
[TBL] [Abstract][Full Text] [Related]
12. Nucleophosmin (NPM1) mutations in adult and childhood acute myeloid leukaemia: towards definition of a new leukaemia entity.
Rau R; Brown P
Hematol Oncol; 2009 Dec; 27(4):171-81. PubMed ID: 19569254
[TBL] [Abstract][Full Text] [Related]
13. Cytoplasmic expression of nucleophosmin 1 as a marker for diagnosing residual disease of acute myeloid leukemia.
Dai Q; Ren Y
Appl Immunohistochem Mol Morphol; 2013 May; 21(3):205-11. PubMed ID: 23591014
[TBL] [Abstract][Full Text] [Related]
14. Increase sensitivity to chemotherapeutical agents and cytoplasmatic interaction between NPM leukemic mutant and NF-kappaB in AML carrying NPM1 mutations.
Cilloni D; Messa F; Rosso V; Arruga F; Defilippi I; Carturan S; Catalano R; Pautasso M; Panuzzo C; Nicoli P; Messa E; Morotti A; Iacobucci I; Martinelli G; Bracco E; Saglio G
Leukemia; 2008 Jun; 22(6):1234-40. PubMed ID: 18401421
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical Detection of NPM1 Mutation in Acute Myeloid Leukemia and its Association With Cup-like Nuclear Morphology of Blasts.
Rastogi P; Naseem S; Varma N; Varma S
Appl Immunohistochem Mol Morphol; 2016 Apr; 24(4):261-7. PubMed ID: 26200838
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies against nucleophosmin mutants: potentials for the detection of acute myeloid leukemia.
Tan S; Zhang L; Zhong XM; Yang ZL; Zhao LY; Gao YJ; Shao HY; Qin FX; Chen XC; Zhang HJ; Chen H; Wang L
Int J Med Sci; 2011; 8(4):309-14. PubMed ID: 21611112
[TBL] [Abstract][Full Text] [Related]
17. Immunophenotype distinction between acute promyelocytic leukaemia and CD15- CD34- HLA-DR- acute myeloid leukaemia with nucleophosmin mutations.
Ferrari A; Bussaglia E; Úbeda J; Facchini L; Aventin A; Sierra J; Nomdedéu JF
Hematol Oncol; 2012 Sep; 30(3):109-14. PubMed ID: 21812014
[TBL] [Abstract][Full Text] [Related]
18. Acute myeloid leukemia with mutated nucleophosmin (NPM1): molecular, pathological, and clinical features.
Falini B
Cancer Treat Res; 2010; 145():149-68. PubMed ID: 20306250
[TBL] [Abstract][Full Text] [Related]
19. NPM1 mutations and cytoplasmic nucleophosmin are mutually exclusive of recurrent genetic abnormalities: a comparative analysis of 2562 patients with acute myeloid leukemia.
Falini B; Mecucci C; Saglio G; Lo Coco F; Diverio D; Brown P; Pane F; Mancini M; Martelli MP; Pileri S; Haferlach T; Haferlach C; Schnittger S
Haematologica; 2008 Mar; 93(3):439-42. PubMed ID: 18268276
[TBL] [Abstract][Full Text] [Related]
20. A surrogate marker to detect nucleophosnim (NPM1) gene mutations in the cytoplasm of acute myeloid leukemia (AML) blast cells in 30 adult Iraqi patients.
Al-Husseinawi EK
Ann Saudi Med; 2013; 33(6):539-46. PubMed ID: 24413856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
